XNCR - Why Shares of Zencor Rose This Week
Shares of Xencor (NASDAQ: XNCR) rose 12.6% this week as of Thursday afternoon, according to data provided by S&P Global Market Intelligence . The stock closed at $28.83 on Friday and then rose as high as $33.06 on Thursday. Xencor stock was up as high as 14.7% for the week before falling a bit later in the day Thursday.
The stock is up more than 1.8% over the past 12 months and up more than 24% so far this year. Xencor has seen a 52-week low of $19.36 and a 52-week high of $35.92.
The healthcare company is a clinical-stage biopharmaceutical company that specializes in engineered monoclonal antibody and cytokine therapies to treat cancer and autoimmune disorders. It didn't have any major announcements this week, but it has been on the upswing in general since it provided a corporate presentation on Jan. 11. The company has more than 20 programs in its Xencor XmAb pipeline and three therapies that have been marketed by Xencor collaborators.
For further details see:
Why Shares of Zencor Rose This Week